Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
Krzysztof Jamroziak, MD, PhD
Advertisement
Articles by Krzysztof Jamroziak, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Building Systems to Catch Liver and Other Cancers in Patients With MASLD
2
Closing the HCC Surveillance Gap in MASLD Without Cirrhosis
3
Rethinking Surveillance and Multidisciplinary Care in MASLD-Related HCC
4
Weighing HCC Surveillance for Patients With MASLD and F3 Fibrosis
5